Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Crutial 450 day data.

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Nov 13, 2022 2:19pm

195 Views

Post# 35095100

RE:Crutial 450 day data.

Thank you, Wildbird for taking the time. Can you or others elaborate a bit on the assumption behind duration of response staying the same? Are you saying once a patient is CR, that patient is likely to maintain CR at future checkpoints? With these 3 cohorts in the data, it can be a little confusing. Also, how much value will the FDA assign to PRs?

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?